zileuton has been researched along with bwa 4c in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreft, AF; Musser, JH | 1 |
| Brooks, CD; Summers, JB | 1 |
| Greiner, C; Koeberle, A; Schubert-Zsilavecz, M; Werz, O; Wurglics, M; Zettl, H | 1 |
| Banoglu, E; Calışkan, B; Luderer, S; Özkan, Y; Werz, O | 1 |
| Hieke, M; Hofmann, B; la Buscató, E; Proschak, E; Rödl, CB; Schubert-Zsilavecz, M; Stark, H; Steinhilber, D; Wisniewska, JM | 1 |
| Barzen, S; Hofmann, B; Lill, A; Rödl, CB; Stark, H; Steinhilber, D | 1 |
| Aparoy, P; de Rosa, M; Filosa, R; Krauth, V; Luderer, S; Massa, A; Peduto, A; Petronzi, C; Reddanna, P; Schaible, AM; Werz, O | 1 |
| Achenbach, J; Barzen, S; Brüggerhoff, A; Hofmann, B; Ihlefeld, K; Kretschmer, SB; Proschak, E; Rödl, CB; Stark, H; Steinhilber, D; Vogt, D | 1 |
| Chamulitrat, W; Mason, RP; Riendeau, D | 1 |
| Falgueyret, JP; Hutchinson, JH; Riendeau, D | 1 |
| Hussey, HJ; Tisdale, MJ | 1 |
2 review(s) available for zileuton and bwa 4c
| Article | Year |
|---|---|
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines | 1992 |
Modulators of leukotriene biosynthesis and receptor activation.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Carrier Proteins; Forecasting; Humans; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Molecular Structure; Receptors, Leukotriene | 1996 |
9 other study(ies) available for zileuton and bwa 4c
| Article | Year |
|---|---|
Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Topics: Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Cyclooxygenase 1; Cyclooxygenase 2; Drug Design; Enzyme Activation; Enzyme Inhibitors; Humans; Inflammation; Inhibitory Concentration 50; Intramolecular Oxidoreductases; Lipoxygenase Inhibitors; Models, Chemical; Prostaglandin-E Synthases; Pyrimidines | 2008 |
Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils.
Topics: Arachidonate 5-Lipoxygenase; Blood Platelets; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Humans; Inhibitory Concentration 50; Leukotrienes; Lipoxygenase Inhibitors; Neutrophils; Propionates; Pyrazoles | 2011 |
SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.
Topics: Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Humans; Leukocytes; Lipoxygenase Inhibitors; Pyridines; Structure-Activity Relationship | 2012 |
Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.
Topics: Arachidonate 5-Lipoxygenase; Cell Survival; Cell-Free System; Cells, Cultured; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Lipoxygenase Inhibitors; Molecular Structure; Neutrophils; Structure-Activity Relationship; Thiazoles | 2012 |
Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase.
Topics: Arachidonate 5-Lipoxygenase; Benzoquinones; Dose-Response Relationship, Drug; Drug Discovery; Humans; Lipoxygenase Inhibitors; Models, Molecular; Molecular Structure; Recombinant Proteins; Resorcinols; Structure-Activity Relationship | 2013 |
Multi-dimensional target profiling of N,4-diaryl-1,3-thiazole-2-amines as potent inhibitors of eicosanoid metabolism.
Topics: 5-Lipoxygenase-Activating Proteins; Aminophenols; Cyclooxygenase 2; Dose-Response Relationship, Drug; Eicosanoids; Enzyme Inhibitors; HeLa Cells; Humans; Molecular Structure; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured; U937 Cells | 2014 |
Nitroxide metabolites from alkylhydroxylamines and N-hydroxyurea derivatives resulting from reductive inhibition of soybean lipoxygenase.
Topics: Benzeneacetamides; Electron Spin Resonance Spectroscopy; Free Radicals; Glycine max; Hydroxamic Acids; Hydroxylamines; Hydroxyurea; Lipoxygenase Inhibitors; Molecular Structure; Nitrogen Oxides; Oxidation-Reduction; Structure-Activity Relationship | 1992 |
Criteria for the identification of non-redox inhibitors of 5-lipoxygenase.
Topics: Arachidonate 5-Lipoxygenase; Benzeneacetamides; Benzofurans; Enzyme Inhibitors; Humans; Hydroxamic Acids; Hydroxyurea; Indoles; Leukotrienes; Lipid Peroxides; Lipoxygenase Inhibitors; Naphthalenes; Oxidation-Reduction; Thiazoles | 1993 |
Inhibition of tumour growth by lipoxygenase inhibitors.
Topics: Adenocarcinoma; Administration, Oral; Analysis of Variance; Animals; Benzeneacetamides; Cell Division; Colonic Neoplasms; Hydroxamic Acids; Hydroxyurea; Lipoxygenase Inhibitors; Male; Mice; Neoplasm Transplantation; Treatment Outcome; Tumor Cells, Cultured | 1996 |